KR100539706B1 - 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 - Google Patents
타크로리무스 및 장용성 고분자를 함유하는 고체분산체 Download PDFInfo
- Publication number
- KR100539706B1 KR100539706B1 KR1020050006872A KR20050006872A KR100539706B1 KR 100539706 B1 KR100539706 B1 KR 100539706B1 KR 1020050006872 A KR1020050006872 A KR 1020050006872A KR 20050006872 A KR20050006872 A KR 20050006872A KR 100539706 B1 KR100539706 B1 KR 100539706B1
- Authority
- KR
- South Korea
- Prior art keywords
- tacrolimus
- solid dispersion
- solubility
- enteric
- present
- Prior art date
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B39/00—Evaporators; Condensers
- F25B39/04—Condensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F28—HEAT EXCHANGE IN GENERAL
- F28F—DETAILS OF HEAT-EXCHANGE AND HEAT-TRANSFER APPARATUS, OF GENERAL APPLICATION
- F28F1/00—Tubular elements; Assemblies of tubular elements
- F28F1/10—Tubular elements and assemblies thereof with means for increasing heat-transfer area, e.g. with fins, with projections, with recesses
- F28F1/12—Tubular elements and assemblies thereof with means for increasing heat-transfer area, e.g. with fins, with projections, with recesses the means being only outside the tubular element
- F28F1/38—Tubular elements and assemblies thereof with means for increasing heat-transfer area, e.g. with fins, with projections, with recesses the means being only outside the tubular element and being staggered to form tortuous fluid passages
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B2339/00—Details of evaporators; Details of condensers
- F25B2339/04—Details of condensers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mechanical Engineering (AREA)
- Thermal Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Geometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
- 삭제
- 삭제
- 타크로리무스 및 장용성 고분자를 함유하는 고체분산체에 있어서,타크로리무스 1중량에 대하여 프탈산히드록시프로필메칠셀룰로오스, 장용성 아크릴레이트 중합체, 히드록시프로필 메틸셀룰로오스 아세테이트 석시네이트 및 카르복시 메틸에칠 셀룰로오스 중에서 선택되는 장용성 고분자를 0.8 내지 1.2 중량비로 함유함을 특징으로 하는 속용성 타크로리무스 고체분산체.
- 삭제
- 삭제
- 삭제
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050006872A KR100539706B1 (ko) | 2005-01-25 | 2005-01-25 | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 |
CA002593825A CA2593825A1 (en) | 2005-01-25 | 2005-12-30 | Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
US11/814,583 US20080132533A1 (en) | 2005-01-25 | 2005-12-30 | Solid Dispersion Comprising Tacrolimus and Entericcoated Macromolecule |
PCT/KR2005/004669 WO2006080778A1 (en) | 2005-01-25 | 2005-12-30 | Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050006872A KR100539706B1 (ko) | 2005-01-25 | 2005-01-25 | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100539706B1 true KR100539706B1 (ko) | 2005-12-28 |
Family
ID=36740738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050006872A KR100539706B1 (ko) | 2005-01-25 | 2005-01-25 | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20080132533A1 (ko) |
KR (1) | KR100539706B1 (ko) |
CA (1) | CA2593825A1 (ko) |
WO (1) | WO2006080778A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012053785A2 (ko) * | 2010-10-19 | 2012-04-26 | Lee Hee-Yub | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2664641A1 (en) * | 2006-09-26 | 2008-04-10 | Astellas Pharma, Inc. | Controlled release dosage form of tacrolimus |
KR20130028824A (ko) * | 2011-09-09 | 2013-03-20 | 주식회사 삼양바이오팜 | 타크로리무스를 포함하는 고체 분산체 및 이의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW212139B (ko) * | 1991-04-15 | 1993-09-01 | Yamanouchi Pharma Co Ltd | |
SK10722003A3 (sk) * | 2001-02-27 | 2004-02-03 | Astrazeneca Ab | Farmaceutická formulácia obsahujúca bicalutamid v pevnej disperzii s enterickým polymérom a jej použitie |
MXPA06000370A (es) * | 2003-07-09 | 2006-03-28 | Chong Kun Dang Pharm Corp | Dispersion solida de tacrolimus. |
-
2005
- 2005-01-25 KR KR1020050006872A patent/KR100539706B1/ko active IP Right Grant
- 2005-12-30 CA CA002593825A patent/CA2593825A1/en not_active Abandoned
- 2005-12-30 US US11/814,583 patent/US20080132533A1/en not_active Abandoned
- 2005-12-30 WO PCT/KR2005/004669 patent/WO2006080778A1/en active Application Filing
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012053785A2 (ko) * | 2010-10-19 | 2012-04-26 | Lee Hee-Yub | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 |
WO2012053785A3 (ko) * | 2010-10-19 | 2012-06-28 | Lee Hee-Yub | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 |
KR101243938B1 (ko) * | 2010-10-19 | 2013-03-19 | 이희엽 | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 |
CN103189054A (zh) * | 2010-10-19 | 2013-07-03 | 李熙烨 | 含有他克莫斯有效成分的缓释微丸 |
US9358210B2 (en) | 2010-10-19 | 2016-06-07 | Hee-Yub Lee | Sustained-release pellets containing tacrolimus as an active ingredient |
Also Published As
Publication number | Publication date |
---|---|
WO2006080778A1 (en) | 2006-08-03 |
CA2593825A1 (en) | 2006-08-03 |
US20080132533A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1302205B1 (en) | Controlled release formulations of macrolide citrate salts | |
RU2342926C2 (ru) | Способ получения низкокристаллического олтипраза или аморфного олтипраза | |
BR112020024107A2 (pt) | combinação farmacêutica, composição, e preparação de combinação que compreende ativador de glucoquinase e inibidor de sglt-2 e métodos de preparação e uso dos mesmos | |
WO2008027600A2 (en) | Imatinib compositions | |
NO346639B1 (no) | Farmasøytiske preparater og fremgangsmåte for fremstilling derav | |
PT2121716E (pt) | Composições de tiacumicinas estáveis | |
TW201311236A (zh) | 塞來昔布固體分散體及其製備方法 | |
US10660963B2 (en) | Pharmaceutical composition containing tacrolimus and preparation methods thereof | |
CN102342907A (zh) | 决奈达隆固体分散体及其制备方法 | |
US20140341993A1 (en) | Solid pharmaceutical composition comprising an antibiotic from the quinolone family and method of production thereof | |
KR20210080225A (ko) | 올라파립의 용해도 및 생체이용율이 개선된 조성물 | |
WO2011051967A2 (en) | Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof | |
KR100539706B1 (ko) | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 | |
CN102406622A (zh) | 一种托伐普坦的固体制剂 | |
US20240173310A1 (en) | Pharmaceutical dosage forms comprising (4s)-24-chloro-4-ethyl-73-fluoro-35-methoxy-32,5-dioxo-14-(trifluoromethyl)-32h-6-aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide | |
US20220273619A1 (en) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same | |
KR20220077094A (ko) | 안정성 및 생체이용율이 개선된 올라파립 고체 분산체 조성물 | |
KR101446129B1 (ko) | 프란루카스트-함유 고형 제제의 제조방법 | |
JP7058104B2 (ja) | アプレピタントを有効成分とする医薬錠剤 | |
KR20190064208A (ko) | 피마살탄을 포함하는 고체 분산체 | |
EA045511B1 (ru) | Состав с афабицином, способ его получения и его применение | |
TW201300106A (zh) | 治療hcv感染之醫藥組合物 | |
GR1009790B (el) | Σκευασμα παρατεταμενης αποδεσμευσης που περιλαμβανει τακρολιμους | |
KR20080109463A (ko) | 페노피브레이트 함유 신규 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121221 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131223 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141222 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20151222 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20161222 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171222 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20181224 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20191223 Year of fee payment: 15 |